Serum levels of ace, angiotensin II and CA19-9 in Egyptian patients with liver cirrhosis and in hepatocellular carcinoma - Egyptian Knowledge Bank - troweb

36988

Serum levels of ace, angiotensin II and CA19-9 in Egyptian patients with liver cirrhosis and in hepatocellular carcinoma

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Serum angiotensin II and angiotensin converting enzyme in Egyptian patients with chronic liver disease

Thesis

Activity of serum angiotensin-converting enzyme as a tumor marker of hepatocellular carcinoma

Thesis

The significance of (SERPINI1, and QP-C) in the diagnosis of hepatocellula carcinoma in chronic HCV Egyptian patients

Thesis

Clinical biochemical markers for hepatocellular carcinoma in Egyptian patients

Thesis

Correlation between CA 19-9 and alpha fetoprotein (AFP) in diagnosed cases of hepatocellular carcinoma

Thesis

Significance of serum chromogranin-A in patients withliver cirrhosis and hepatocellular carcinoma

Thesis

A study of risk factors of hepatocellular carcinomaamong Egyptian patients

Thesis

A study of risk factors of hepatocellular carcinoma among Egyptian patients

Thesis

Significance of angiopoietin-2 as a serum marker for hepatocellular carcinoma

Thesis

Evaluation of serum levels of adiponectin in Egyptian patients with hepatitis c relatedchronic liver disease